News

<- Back

West Jefferson Medical Center Joins Growing Group of Imaging Centers Installing SoftVue Breast Ultrasound Tomography

July 30, 2024

Center’s Chief Nursing Officer Monica Bologna, MSN, RN, CENP says new breast imaging system fills a screening gap for women with dense breasts in the Louisiana region

NOVI, Mich. – July 30, 2024 - Delphinus Medical Technologies, today announced the latest installation of its breakthrough dense breast imaging technology SoftVue™ Breast Ultrasound Tomography (UST) at West Jefferson Medical Center in Louisiana.

“The launch of West Jefferson Medical Center’s SoftVue Dense Breast Screening Program demonstrates the expanding adoption of SoftVue across the country. West Jefferson joins a growing group of progressive health centers investing in Delphinus’s advanced breast ultrasound tomography as an adjunct to mammography, to better serve the 50 percent of women with dense breasts screened annually,” said Scott White, CEO of Delphinus Medical Technologies. “The proactive approach taken by the West Jefferson Medical Center team to improve patient outcomes for women with dense breasts is in lockstep with our mission to enable the early detection of breast cancer.”

SoftVue UST is the only imaging modality designed specifically to find more cancer in women with dense breasts and is also the only ultrasound-based breast imaging system that is FDA-approved for same-day screening as mammography. Delphinus designed the system as an adjunct to mammography for women with dense breasts to address the fact that breast cancer screening with mammography alone reduces mortality by 41% in women with non-dense breasts but reduces mortality by only 13% in women with dense breasts.

“We recognize that women with dense breasts need screening in addition to mammograms, as cancers can hide in dense breast tissue on x-ray, but until now our breast center lacked an efficient and effective modality,” said Monica Bologna, MSN, RN, CENP, chief nursing officer at West Jefferson Medical Center – LCMC Health. “SoftVue offers a screening solution for this patient population that not only increases cancer detection, but also improves our workflow and the patient experience which is what has been missing in our breast center.”

When combined with mammography, SoftVue increases sensitivity by 20 percent and specificity by eight percent, offering comprehensive characterization at the point of screening which helps increase cancer detection and reduce short-term follow-ups. In addition, SoftVue can be performed during the same visit as the women’s mammogram, saving patients time and improving the diagnostic clinical workflow for a bustling breast center.